文献速递临床试验与 GCP流行病学与生物统计

基于助推的视觉叙事在巴基斯坦非复杂性尿路感染抗生素依从性中的效果:随机对照试验方案

Effectiveness of nudge-based visual storytelling in antibiotic adherence in uncomplicated urinary tract infection in Pakistan: protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2025-12-17

本研究为在巴基斯坦开伯尔-普赫图赫瓦省六家三级医院开展的平行两组优效性随机对照试验方案,拟纳入医生确诊的非复杂性尿路感染且已取口服抗生素处方的患者,1:1随机接受VISTA干预或标准护理。VISTA为基于助推理论和选择架构分类框架、经德尔菲法开发验证的贴纸工具,主要结局为初次随访时药片计数法测量的依从性,次要结局包括尿路感染复发、知识和态度。

要点

  • VISTA干预为基于助推理论和文化定制的贴纸工具,用红绿对比色传达不依从与依从的后果。
  • 主要结局为初次随访时药片计数法测量的依从性,次要结局包括尿路感染复发、知识和态度。
  • 分析将遵循意向性治疗和符合方案原则,试验已在ClinicalTrials.gov注册(NCT06885658)。

核心结论

  • 该随机对照试验将评估一种理论驱动、可扩展的干预措施在低资源、低连接性环境中的效果,与世界卫生组织缓解抗生素耐药的重点方向一致。

研究设计与样本

  • 平行两组优效性随机对照试验,从巴基斯坦开伯尔-普赫图赫瓦省六家三级医院招募医生确诊的非复杂性尿路感染且已取口服抗生素处方的参与者,1:1随机分配接受VISTA干预或标准护理。
  • VISTA干预基于助推理论、以选择架构分类框架为指导,并辅以MINDSPACE框架,通过德尔菲法开发验证并根据患者理解研究进行完善。

主要发现

  • 原文为试验方案,未报告试验结果。

关键数值与推荐

  • 主要结局为初次随访时通过药片计数法测量的依从性。
  • 次要结局包括尿路感染复发、关于抗生素依从性的知识和态度。
  • 分析将遵循意向性治疗和符合方案原则。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 药片计数法可能遗漏有意不依从,将尿路感染复发作为次要结局有助于减轻这一问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibiotic resistance (ABR) is a global health threat, significantly driven by its misuse. The World Health Organization stresses the need for better antibiotic use to combat ABR through behavioral change interventions. Visual storytelling, which merges narrative with visuals, can enhance health behaviors by boosting cognitive and emotional engagement. In Pakistan, more than half of the population lack access to mobile phone, limiting digital health solutions. To address this gap, we developed a culturally tailored Visual Storytelling for Antibiotic Adherence (VISTA) intervention - a theory-driven sticker-based tool - to improve antibiotic adherence among urinary tract infection (UTI) patients in low-connectivity settings. METHODS: In this parallel, two-arm superiority randomized controlled trial, participants with physician-confirmed uncomplicated UTI who have filled an oral antibiotic prescription will be recruited from six tertiary care hospitals in Khyber Pakhtunkhwa, Pakistan. The participants will be randomized in a 1:1 manner to receive either the VISTA intervention or standard care. The VISTA intervention was developed based on nudge theory, guided by the Taxonomy of Choice Architecture framework, and complemented by the MINDSPACE (messenger, incentives, norms, defaults, salience, priming, affect, commitments, and ego) framework. It was developed and validated through a Delphi method, assessing expert feedback, and refined based on a patient understanding study. The intervention sticker uses contrasting colors-red (non-adherence: bacteria evolving into "superbugs") and green (adherence: antibiotics fully eradicating bacteria)-to communicate the consequences of incomplete versus complete adherence. The primary outcome is adherence, measured by pill count at the initial follow-up. Secondary outcomes include UTI recurrence, knowledge, and attitudes regarding antibiotic adherence. Analysis will follow both intention-to-treat and per-protocol principles. DISCUSSION: This randomized controlled trial will evaluate a theory-driven, scalable intervention for low-resource, low-connectivity settings, aligning with WHO priorities for ABR mitigation. It addresses the patient support gap caused by limited digital access. Pill counts provide an objective adherence measure, though they may miss intentional non-adherence; including UTI recurrence as a secondary outcome helps mitigate this. Cultural tailoring through expert panels and patient feedback aims to enhance relevance and applicability across similar contexts, improving generalizability. TRIAL REGISTRATION: The trial was registered with ClinicalTrials.gov (registered: March 13, 2025, NCT06885658, https://clinicaltrials.gov/study/NCT06885658 ).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hussain I, Rasool MF, Ullah J, et al. Effectiveness of nudge-based visual storytelling in antibiotic adherence in uncomplicated urinary tract infection in Pakistan: protocol for a randomized controlled trial. Trials. 2025. PMID: 41408333. doi:10.1186/s13063-025-09328-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。